Greenlane Holdings, Inc. (GNLN) - 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2025. Greenlane Holdings, Inc. is a global platform for premium cannabis accessories, vaporization solutions, and lifestyle products. The company operates through a single reportable segment and utilizes an "Up-C" corporate structure. During the quarter, the company completed a one-for-750 reverse stock split effective June 25, 2025.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $0.8 million | $2.7 million | $2.3 million | $7.6 million |
| Gross Profit | $0.002 million | $1.0 million | $0.7 million | $2.5 million |
| Gross Margin | 0% | 38% | 32% | 33% |
| Net Loss | $(3.2) million | $(0.6) million | $(7.1) million | $(5.1) million |
| Cash and Equivalents | $5.7 million | $0.2 million | $5.7 million | $0.2 million |
| Working Capital | $16.3 million | $1.5 million | $16.3 million | $1.5 million |
| Total Debt | $0 | $7.7 million | $0 | $7.7 million |
Note: All share and per-share amounts have been retroactively adjusted for the reverse stock split.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 70% year-over-year for both the quarter and the six-month period. Management attributes this to a strategic focus on profitable revenue and the temporary impact of reorganizing the sales team.
- Margin Compression: Gross margin collapsed to 0% in Q2 2025 (down from 38% in Q2 2024) due to write-offs of slow-moving inventory. YTD gross margin was 32%.
- Debt Elimination: The company repaid all outstanding debt (approximately $8.0 million) in February 2025 using proceeds from a private placement. Consequently, interest expense dropped to zero for the current period.
- Liquidity Improvement: Cash on hand increased from $0.9 million at year-end 2024 to $5.7 million at June 30, 2025, driven by a $25.0 million private placement in February 2025.
- Operating Expenses: Total operating expenses decreased 28% year-over-year for the quarter, primarily due to workforce reductions and facility rationalization.
Outlook, Risks, and Management Commentary
- Going Concern: The company has incurred significant losses and negative operating cash flows. Management states that the ability to continue as a going concern is contingent upon executing a plan to reduce costs, increase revenue, and potentially seek additional capital. The financial statements do not include adjustments related to this uncertainty.
- Strategic Initiatives: Management is focusing on facility footprint rationalization, headcount reduction, inventory lifecycle management, and new product lines (e.g., pet wellness). New distribution agreements were signed with Greentank Technologies and ALD Group Limited.
- Nasdaq Compliance: The company faced delisting risks due to bid price requirements but regained compliance in July 2025 following a hearing. However, it is subject to a one-year discretionary monitor.
- Legal Contingencies: The company is defending against multiple antitrust class actions regarding Ccell products and a False Claims Act investigation regarding a PPP loan. No reserves have been recorded for these matters.
- Internal Controls: Disclosure controls and procedures were deemed ineffective as of June 30, 2025, due to material weaknesses in internal control over financial reporting that remain unremediated.
Investor Verification Checklist
- Cash Burn Rate: Verify the sustainability of the $5.7 million cash balance given the $7.9 million cash burn from operations in the first six months of 2025.
- Inventory Valuation: Assess the adequacy of inventory reserves given the 0% gross margin in Q2 and the specific mention of slow-moving inventory write-offs.
- Revenue Recovery: Monitor the effectiveness of the new sales leadership and restructuring in reversing the 70% revenue decline.
- Legal Exposure: Track the status of the antitrust lawsuits and the False Claims Act investigation, as adverse outcomes could result in significant liabilities.
- Internal Controls: Review the progress of the remediation plan for material weaknesses in internal controls, which impacts the reliability of financial reporting.